- Home
- RANI vs BGI Comparison
RANI vs BGI Comparison
Compare RANI & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- BGI
- Stock Information
- Founded
- RANI 2012
- BGI 1879
- Country
- RANI United States
- BGI Canada
- Employees
- RANI N/A
- BGI N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- BGI
- Sector
- RANI Health Care
- BGI
- Exchange
- RANI Nasdaq
- BGI Nasdaq
- Market Cap
- RANI 19.6M
- BGI 18.0M
- IPO Year
- RANI 2021
- BGI 2005
- Fundamental
- Price
- RANI $0.50
- BGI $0.91
- Analyst Decision
- RANI Strong Buy
- BGI
- Analyst Count
- RANI 4
- BGI 0
- Target Price
- RANI $7.75
- BGI N/A
- AVG Volume (30 Days)
- RANI 317.2K
- BGI 57.4K
- Earning Date
- RANI 08-05-2025
- BGI 07-15-2025
- Dividend Yield
- RANI N/A
- BGI N/A
- EPS Growth
- RANI N/A
- BGI N/A
- EPS
- RANI N/A
- BGI N/A
- Revenue
- RANI $1,200,000.00
- BGI $131,596,265.00
- Revenue This Year
- RANI N/A
- BGI N/A
- Revenue Next Year
- RANI N/A
- BGI N/A
- P/E Ratio
- RANI N/A
- BGI N/A
- Revenue Growth
- RANI N/A
- BGI 4.01
- 52 Week Low
- RANI $0.46
- BGI $0.76
- 52 Week High
- RANI $4.37
- BGI $2.99
- Technical
- Relative Strength Index (RSI)
- RANI 29.91
- BGI 51.08
- Support Level
- RANI $0.51
- BGI $0.86
- Resistance Level
- RANI $0.56
- BGI $0.93
- Average True Range (ATR)
- RANI 0.04
- BGI 0.07
- MACD
- RANI 0.01
- BGI 0.01
- Stochastic Oscillator
- RANI 0.38
- BGI 72.29
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.